SCHEMBL6489535

SCHEMBL6489535

[CH2][C@H](O)C(Oc1ccccc1)C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 2/20 0.37
CYP2D6 P10635 1/20 0.37
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
TDP1 Q9NUW8 1/20 0.35
TRPA1 O75762 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
GAA P10253 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
PKM P14618 1/20 0.33
CYP2C19 P33261 1/20 0.33
CA4 P22748 1/20 0.33
ALDH1A1 P00352 3/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16058603 0.80 CYP1A2 (0.38) ATMLMNACYP2D6KMT2AGAA
SCHEMBL295469 0.75 ATM (0.43) ATML3MBTL1LMNACYP2D6MEN1
SCHEMBL17896180 0.74 ATM (0.40) ATML3MBTL1LMNACYP2D6MEN1
SCHEMBL17896179 0.74 ATM (0.40) ATML3MBTL1LMNACYP2D6MEN1
SCHEMBL1252991 0.74 LMNA (0.45) LMNACYP2D6MEN1KMT2AMTNR1A
SCHEMBL6490893 0.73 ATM (0.33) ATML3MBTL1KDM4E
SCHEMBL15234013 0.73 LMNA (0.39) LMNAMEN1KMT2AMTNR1AMTNR1B
SCHEMBL28663493 0.73 LMNA (0.39) ATMLMNAMEN1KMT2AMTNR1A
SCHEMBL16671569 0.72 LMNA (0.41) LMNAMEN1KMT2AMTNR1AMTNR1B
SCHEMBL4248694 0.71 LMNA (0.42) ATML3MBTL1LMNACYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050222247-A1 Chroman derivatives BAYER HEALTHCARE AG (DE) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222247-A1 Chroman derivatives CHRM3, CHRNB3, ADRB3 ATM 2431/4885L3MBTL1 3998/4885LMNA 1138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.